{"entity":{"type":"insider","cik":"0001753222","url":"/insider/0001753222","json_url":"/insider/0001753222.json","name":"Moller-San Pedro Claus Juan","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":7,"n_filings":4,"first":"2018-09-25","last":"2020-12-04","span_basis":"filed_date"},"name_variants":[{"name":"Moller-San Pedro Claus Juan","source":"filing","n_filings":3,"first_seen":"2020-03-19","last_seen":"2020-12-04"},{"name":"Juan Moller San Pedro Claus","source":"filing","n_filings":1,"first_seen":"2018-09-25","last_seen":"2018-09-25"}],"transactions":[{"id":2612142,"accession":"0001104659-20-132165","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001104659-20-132165","line_url":"/filing/0001104659-20-132165#line-2","is_derivative":false,"issuer_cik":"0001722964","issuer_name":"Y-mAbs Therapeutics, Inc.","issuer_ticker":"YMAB","issuer_name_source":null,"issuer_url":"/issuer/0001722964","owner_cik":"0001753222","owner_name":"Moller-San Pedro Claus Juan","owner_display_name":"Moller-San Pedro Claus Juan","owner_url":"/insider/0001753222","role":"Director, Officer (Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":9266.0,"shares_display":"9,266","price_per_share":50.9796,"price_display":"50.98","price_state":"stated","total_value":472376.9736,"total_display":"472,376.97","total_whole":"472,377","shares_owned_after":607303.0,"shares_owned_after_display":"607,303","ownership_form":"I","is_10b5_1":null,"transaction_date":"2020-12-03","filed_date":"2020-12-04","scope":"insider"},{"id":2612137,"accession":"0001104659-20-132165","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001104659-20-132165","line_url":"/filing/0001104659-20-132165#line-1","is_derivative":false,"issuer_cik":"0001722964","issuer_name":"Y-mAbs Therapeutics, Inc.","issuer_ticker":"YMAB","issuer_name_source":null,"issuer_url":"/issuer/0001722964","owner_cik":"0001753222","owner_name":"Moller-San Pedro Claus Juan","owner_display_name":"Moller-San Pedro Claus Juan","owner_url":"/insider/0001753222","role":"Director, Officer (Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":40734.0,"shares_display":"40,734","price_per_share":51.2654,"price_display":"51.27","price_state":"stated","total_value":2088244.8036,"total_display":"2,088,244.80","total_whole":"2,088,245","shares_owned_after":616569.0,"shares_owned_after_display":"616,569","ownership_form":"I","is_10b5_1":null,"transaction_date":"2020-12-02","filed_date":"2020-12-04","scope":"insider"},{"id":2611233,"accession":"0001104659-20-062625","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001104659-20-062625","line_url":"/filing/0001104659-20-062625#line-2","is_derivative":false,"issuer_cik":"0001722964","issuer_name":"Y-mAbs Therapeutics, Inc.","issuer_ticker":"YMAB","issuer_name_source":null,"issuer_url":"/issuer/0001722964","owner_cik":"0001753222","owner_name":"Moller-San Pedro Claus Juan","owner_display_name":"Moller-San Pedro Claus Juan","owner_url":"/insider/0001753222","role":"Director, Officer (Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":139154.0,"shares_display":"139,154","price_per_share":36.0248,"price_display":"36.02","price_state":"stated","total_value":5012995.0192,"total_display":"5,012,995.02","total_whole":"5,012,995","shares_owned_after":657303.0,"shares_owned_after_display":"657,303","ownership_form":"I","is_10b5_1":null,"transaction_date":"2020-05-14","filed_date":"2020-05-15","scope":"insider"},{"id":2611231,"accession":"0001104659-20-062625","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001104659-20-062625","line_url":"/filing/0001104659-20-062625#line-1","is_derivative":false,"issuer_cik":"0001722964","issuer_name":"Y-mAbs Therapeutics, Inc.","issuer_ticker":"YMAB","issuer_name_source":null,"issuer_url":"/issuer/0001722964","owner_cik":"0001753222","owner_name":"Moller-San Pedro Claus Juan","owner_display_name":"Moller-San Pedro Claus Juan","owner_url":"/insider/0001753222","role":"Director, Officer (Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":60846.0,"shares_display":"60,846","price_per_share":37.7531,"price_display":"37.75","price_state":"stated","total_value":2297125.1226,"total_display":"2,297,125.12","total_whole":"2,297,125","shares_owned_after":796457.0,"shares_owned_after_display":"796,457","ownership_form":"I","is_10b5_1":null,"transaction_date":"2020-05-13","filed_date":"2020-05-15","scope":"insider"},{"id":2743030,"accession":"0001104659-20-035949","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001104659-20-035949","line_url":"/filing/0001104659-20-035949#line-1","is_derivative":false,"issuer_cik":"0001722964","issuer_name":"Y-mAbs Therapeutics, Inc.","issuer_ticker":"YMAB","issuer_name_source":null,"issuer_url":"/issuer/0001722964","owner_cik":"0001753222","owner_name":"Moller-San Pedro Claus Juan","owner_display_name":"Moller-San Pedro Claus Juan","owner_url":"/insider/0001753222","role":"Director, Officer (Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":1900.0,"shares_display":"1,900","price_per_share":17.2166,"price_display":"17.22","price_state":"stated","total_value":32711.54,"total_display":"32,711.54","total_whole":"32,712","shares_owned_after":1900.0,"shares_owned_after_display":"1,900","ownership_form":"I","is_10b5_1":null,"transaction_date":"2020-03-17","filed_date":"2020-03-19","scope":"insider"},{"id":6747969,"accession":"0001104659-18-058453","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001104659-18-058453","line_url":"/filing/0001104659-18-058453","is_derivative":false,"issuer_cik":"0001722964","issuer_name":"Y-mAbs Therapeutics, Inc.","issuer_ticker":"YMAB","issuer_name_source":null,"issuer_url":"/issuer/0001722964","owner_cik":"0001753222","owner_name":"Juan Moller San Pedro Claus","owner_display_name":"Juan Moller San Pedro Claus","owner_url":"/insider/0001753222","role":"Director, Officer (Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":31250.0,"shares_display":"31,250","price_per_share":16.0,"price_display":"16.00","price_state":"stated","total_value":500000.0,"total_display":"500,000.00","total_whole":"500,000","shares_owned_after":872928.0,"shares_owned_after_display":"872,928","ownership_form":"I","is_10b5_1":null,"transaction_date":"2018-09-25","filed_date":"2018-09-25","scope":"insider","n_lines":2}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":7,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":3,"open_market":true},{"code":"S","label":"Open-market sale","n":4,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":7},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001722964","name":"Y-mAbs Therapeutics, Inc.","url":"/issuer/0001722964","role":"Director, Officer (Chief Executive Officer)","n_filings":4,"first_seen":"2018-09-25","last_seen":"2020-12-04"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001753222","retrieved_at":"2026-08-26T04:37:29+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-24","last_ingest":"2026-08-25T05:24:19.374141+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}